Review
Open access
Sep 2026
Brain-Targeting siRNA Delivery to Tackle Alzheimer's Disease.
Both the therapeutic promise and the realistic limitations of siRNA-based approaches for AD are discussed, priorities for future development are outlined, and key gaps that must be addressed are identified to enable meaningful clinical implementation.
Qingshan Yang, Zhou-Chun Chen, Jian-Chao Zhu et al.
· Wiley Interdisciplinary Revi... · 0 citations